The influence of smoking on the risk of Alzheimer's disease

Neurology

Volumn 52, Issue 7, 1999, Pages 1408-1412

  Merchant, C ^a,b   Tang, M X ^a,b   Albert, S ^a,b   Manly, J ^a,b   Stern, Y ^a,b   Mayeux, Richard ^a,b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CIGARETTE SMOKING; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING CESSATION;

EID: 0033594437     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.7.1408     Document Type: Article

References (32)

1. 3H) nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology 1988;39:720-723.
2. Shimohama S, Taniguchi T, Fujiwara M, et al. Changes in nieotinic and muscarinic cholinergic receptors in Alzheimertype dementia. J Neurochem 1986;46:288-293.
3. Bird TD, Stranahan S, Sumi SM, Raskind M. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 1983;14:284-293.
4. Perry EK, Gibson PH, Blessed G, et al. Neurotransmitter enzyme abnormalities in senile dementia. J Neurol Sci 1977;34: 247-265.
5. Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986.
6. Riggs JE. The protective influence of cigarette smoking on Alzheimer's and Parkinson's diseases: quagmire or opportunity for neuroepidemiology? Neurol Clin 1996;14:353-358.
7. Riggs JE. Smoking and Alzheimer's disease: protective effect or differential survival bias? Lancet 1993;342:793-794.
8. Ott A, Slooter AJC, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998;351:1840-1843.
9. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-1255.
10. VanDuijn CM, Havekes LM, Van Broeckhoven C, et al. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ 1995;310:627-631.
11. Hardy J, Roberts GW. Smoking and neurodegenerative disease. Lancet 1993;342:1238. Letter.
12. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogenous population: development of a neuropsychological paradigm and quantified correction for education. Arch Neurol 1992;49:453-460.
13. Pittman J, Andrews H, Tatemichi T, et al. Diagnosis of dementia in a heterogenous population: a comparison of paradigm-based diagnosis and physician's diagnosis. Arch Neurol 1992;49:461-467.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
15. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
16. Hughes CP, Berg L, Daniziger WL, Cohen LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychol 1982;140:566-572.
17. The Bureau of the Census of Population and Housing. 1990: Summary tape file 1. Washington, DC: The Bureau of Census, 1991.
18. Mayeux R, Ottman R, Tang M-X, et al. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and the first degree relatives. Ann Neurol 1993;33:494-501.
19. Hixson JE. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb 1991;11:1237-1244.
20. Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1991;31:545-548.
21. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-259.
22. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley and Sons, 1981.
23. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time scale. Am J Epidemiol 1997;145:72-80.
24. Larrick JW, Wright SC. Smoking and neurodegenerative diseases. Lancet 1993;342:1238.
25. Plassman BL, Helms M, Welsh K, et al. Smoking, Alzheimer's disease, and confounding with genes. Lancet 1995;345:387.
26. 2 repair and aging: influence of donor age on chromosomal aberrations in human lymphocytes. Mutat Res 1993; 295:55-62.
27. Au WW, Walker DM, Ward JB, et al. Factors contributing to chromosome damage in lymphocytes of cigarette smokers. Mutat Res 1991;260:137-144.
28. Cruickshank JM, Neil-Dwyer G, Dorrance DE, Hayes Y, Patel S. Acute effects of smoking on blood pressure and cerebral blood flow. J Hum Hypertens 1989;3:443-449.
29. Boerrigter METI, Wej JY, Vijg J. DNA repair and Alzheimer's disease. J Gerontol 1992;47:177-184.
30. Doll R, Peto R, Wheatly K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994;309:901-911.
31. Lockery SA, Stanford EP. Physical activity and smoking: gender comparisons among older African-American adults. J Health Care Poor Underserved 1996;7:232-251.
32. Siegel D, Faigeles B. Smoking and socioeconomic status in a population-based inner city sample of African-Americans, Latinos, and whites. J Cardiovasc Risk 1996;3:295-300.